EMCDDA home pageEuropean Drug Report 2016
European Drug Report 2016
What are the latest trends in drug supply to Europe? What drugs are causing the most harm and concern today? What are the most recent developments in drug prevention, treatment and policy? These and other questions will be explored on 31 May in our annual overview of the European drug situation. #EDR2016
Launch details
Date: 31 May 2016
Time: 10:00 Western European Time (Lisbon) (11:00 Central European Time) Venue: Conference Centre, Praça Europa 4, Cais do Sodré, 1249-206, Lisbon
Perspectives on drugs
These designed-for-the-web analyses incorporate video and interactive features, providing deeper insights into a selection of important issues.
New for 2016:
Also updated:
National data
Other national products
Download the report
European Drug Report 2016:
Trends and Developments
The health risks of high-potency products, the continued emergence of new substances, and changing patterns of drug use are among the issues highlighted in the European Drug Report 2016: Trends and Developments. The report also examines concern over rises in overdose deaths in some countries and the threats posed by internet drug markets.
View this report in our Publications database or download directly using the links below.
PDF Download
24 languages, perfect for laptop, desktop or printing
- bg - български
- es - español
- cs - čeština
- da - dansk
- de - Deutsch
- et - eesti keel
- el - ελληνικά
- en - English
- fr - français
- hr - hrvatski
- it - italiano
- lv - latviešu valoda
- lt - lietuvių kalba
- hu - magyar
- nl - Nederlands
- no - Nynorsk
- pl - polski
- pt - português
- ro - română
- ru - pycckий
- sk - slovenčina
- sl - slovenščina
- fi - suomi
- sv - svenska
- tr - türkçe
- home page
ePUB
Designed for mobiles and tablets (English only).
Interactive/online version — coming soon
Press material
- Speech (in French) by Laura d’Arrigo, Présidente du Conseil d’administration de l’EMCDDA
- Speech of Dimitris Avramopoulos, European Commissioner responsible for Migration, Home Affairs and Citizenship
- EMCDDA highlights new health risks as products and patterns of use change (31.05.2016)
- Coming up: European Drug Report 2016 (20.04.2016)
Promotional items
Video of press conference
Audiovisual material
Motion graphics
European Drug Report 2016: Trends and Developments in Europe's drug situation
Cannabis resin production explained
Drug use problems and mental health: comorbidity explained
Opioid substitution treatment explained
Other audiovisual material
Recoding of press conference:
National launches
Cyprus
Date of event: 31 May
Venue: Nicosia
EMCDDA staff present: Roland Simon, Head of unit — Consequences, responses and best practices unit
Czech Republic
Date of event: 31 May
Venue: Prague
EMCDDA staff present: Linda Montanari, Principal scientific analyst — TDI, treatment and social exclusion
Slovakia
Date of event: 31 May
Venue: Bratislava
EMCDDA staff present: Cláudia Costa Storti, Scientific analyst — Economic analysis
Latvia
Date of event: 2 June
Venue: Rīga
EMCDDA staff present: Julian Vicente, Head of unit — Prevalence, data management and content coordination unit
Sweden
Date of event: 7 June
Venue: Stockholm
EMCDDA staff present: Alexis Goosdeel, Director
Slovenia
Date of event: 19 October
Venue: Ljubljana
EMCDDA staff present: Gregor Burkhart, Principal scientific analyst — prevention